Inhibin as a marker for ovarian cancer (Q36080824)

12 August 2017

Inhibin as a marker for ovarian cancer (English)

1 reference

12 August 2017

1 reference

Cooke I

1

1 reference

12 August 2017

O'Brien M

2

1 reference

12 August 2017

Charnock FM

3

1 reference

12 August 2017

Groome N

4

1 reference

12 August 2017

Ganesan TS

5

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 May 1995

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

71

1 reference

12 August 2017

5

1 reference

12 August 2017

1046-1050

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1995.201

12 August 2017

0 references

cites work

Clinical review 46: Clinical utility of inhibin measurements

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033765

Assays for follicle stimulating hormone and luteinising hormone: guidelines for the provision of a clinical biochemistry service

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033765

Inhibin as a marker for granulosa-cell tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033765

Oocyte donation: a review.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033765

The CA 125 tumour-associated antigen: a review of the literature

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033765

Circulating immunoreactive inhibin levels during the normal human menstrual cycle

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033765

Measurement of exogenous and endogenous inhibin in sheep serum using a new and extremely sensitive bioassay for inhibin based on inhibition of ovine pituitary FSH secretion in vitro.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033765

Survival after ovarian granulosa and theca cell tumours

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033765

Development of a specific and sensitive two-site enzyme-linked immunosorbent assay for measurement of inhibin-A in serum

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033765

Immunoassays for inhibin and its subunits. Further applications of the synthetic peptide approach

23 September 2018

1 reference

12 December 2020

Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay

1 reference

12 December 2020

Immunoreactive inhibin alpha-subunit in human serum: implications for radioimmunoassay

1 reference

12 December 2020

DUAL ENDOCRINE ACTIVITY OF THE TESTES

1 reference

12 December 2020

A standardised multicentre procedure for plasma gonadotrophin radioimmunoassay

1 reference

12 December 2020

Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.201

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

7734297

1 reference